New study achieves 99 percent remission in children who relapse with most common childhood cancer
A recent collaboration with colleagues in Shanghai Children’s Medical Center has found a new immunotherapy combination that resulted in remission for virtually all children – 99 percent – who had relapsed B-cell acute lymphoblastic leukemia (ALL).